BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19499253)

  • 1. Synthesis, characterization, and reaction pathways for the formation of a GMP adduct of a cytotoxic thiocyanato ruthenium arene complex.
    Wang F; Habtemariam A; van der Geer EP; Deeth RJ; Gould R; Parsons S; Sadler PJ
    J Biol Inorg Chem; 2009 Sep; 14(7):1065-76. PubMed ID: 19499253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
    Chen H; Parkinson JA; Morris RE; Sadler PJ
    J Am Chem Soc; 2003 Jan; 125(1):173-86. PubMed ID: 12515520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.
    Wang F; Habtemariam A; van der Geer EP; Fernández R; Melchart M; Deeth RJ; Aird R; Guichard S; Fabbiani FP; Lozano-Casal P; Oswald ID; Jodrell DI; Parsons S; Sadler PJ
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18269-74. PubMed ID: 16352726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cancer cell growth by ruthenium(II) arene complexes.
    Morris RE; Aird RE; Murdoch Pdel S; Chen H; Cummings J; Hughes ND; Parsons S; Parkin A; Boyd G; Jodrell DI; Sadler PJ
    J Med Chem; 2001 Oct; 44(22):3616-21. PubMed ID: 11606126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
    Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cysteine thiols on the catalytic and anticancer activity of Ru(II) sulfonyl-ethylenediamine complexes.
    Chen F; Romero-Canelón I; Habtemariam A; Song JI; Banerjee S; Clarkson GJ; Song L; Prokes I; Sadler PJ
    Dalton Trans; 2022 Mar; 51(11):4447-4457. PubMed ID: 35226015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
    Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ
    J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
    Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
    Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.
    Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ
    Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalysis of regioselective reduction of NAD+ by ruthenium(II) arene complexes under biologically relevant conditions.
    Yan YK; Melchart M; Habtemariam A; Peacock AF; Sadler PJ
    J Biol Inorg Chem; 2006 Jun; 11(4):483-8. PubMed ID: 16604356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Dalton Trans; 2012 Oct; 41(38):11608-18. PubMed ID: 22903512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential.
    Giannini F; Furrer J; Ibao AF; Süss-Fink G; Therrien B; Zava O; Baquie M; Dyson PJ; Stěpnička P
    J Biol Inorg Chem; 2012 Aug; 17(6):951-60. PubMed ID: 22707191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.
    Wang F; Chen H; Parsons S; Oswald ID; Davidson JE; Sadler PJ
    Chemistry; 2003 Dec; 9(23):5810-20. PubMed ID: 14673852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.